LOGCLogicBio Therapeutics, Inc.
11.55USD+2.21%Mkt Cap: 517.02M $P/E:

ContextLogic Holdings Inc. focuses on seeking to develop and grow a de novo business and finance potential future bolt-on acquisitions of assets or businesses. The company was incorporated in 2010 and is headquartered in…

HeadlineSourceTime
Older
LogicBio Therapeutics: ContextLogic Unveils $850M gChem Specialty Chemicals Acquisition

ContextLogic announced plans to acquire Gaylord Chemical Company, known as gChem, for $850 million in a cash transaction, marking the company’s second operating-business acquisition following its purchase of US Salt. Chairman Raja Bobbili said the deal advances ContextLogic’s strategy of assembling

MarketBeat
Plural Investing’s Thoughts on ContextLogic (LOGC)

Plural Investing LLC, an investment advisor, released its Q4 2025 “Plural Partners Fund L.P” investor letter. A copy of the letter can be downloaded here. The Fund posted a net return of 5.7% in the fourth quarter. As value investors, the Firm seeks to invest in companies that are significantly undervalued based on their trading […]

IInsider Monkey
ContextLogic Buys US Salt In $907.5 Million Deal

Deal marks a bold reset after the company's steep decline

GuruFocus.com